Acorda Therapeutics (ACOR): Q2 EPS of $0.27 in-line. Revenue of $75.7M (+15.9% Y/Y) beats by...

|About: Acorda Therapeutics, Inc. (ACOR)|By:, SA News Editor
Acorda Therapeutics (ACOR): Q2 EPS of $0.27 in-line. Revenue of $75.7M (+15.9% Y/Y) beats by $3.1M. (PR)